Graft-Versus-Host Disease(GVHD): Clinical Trials

3 trials for Graft-Versus-Host Disease(GVHD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 11Enrolling by invitation 1

Follow Graft-Versus-Host Disease(GVHD): new trials by email Literature Review of Graft-Versus-Host Disease(GVHD) trials Research Report on Graft-Versus-Host Disease(GVHD)

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments
Subconjuntival injection of expanded allogenic adult adipose tissue-derived mesenchymal stem cells (ASC - Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)
Phase 2Not yet recruitingInstituto de Investigación Biomédica de Salamanca302026-10-012026-09-03
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
Low-dose ATG + PTCy + Ivarmacitinib - Graft-Versus-Host Disease(GVHD), Bone Marrow Transplantation
Phase 2RecruitingShanghai General Hospital, Shanghai Jiao Tong University School of Medicine822026-05-012026-05-06
Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.
Omega-3 Lipid Emulsion - Graft-Versus-Host Disease(GVHD)
Phase 1 / Phase 2Enrolling by invitationFujian Medical University302025-05-162025-11-18

Narrower conditions

Graft vs Host Disease (3)  ·  Dry Eye Syndromes (1)

Broader conditions

Immune System Diseases (3)  ·  Eye Diseases (1)  ·  Lacrimal Apparatus Diseases (1)

Interventions

Docosahexaenoic Acids (1)  ·  ivarmacitinib (1)

Sponsors

Fujian Medical University (1)  ·  Instituto de Investigación Biomédica de Salamanca (1)  ·  Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (2)

Top investigators

Mi Kwon MD, PhD, Medical Degree in Haematology (1)  ·  Ting Yang, MD, PhD (1)  ·  Xianmin Song, PhD (1)